SC
ASLN

Steven Cohen’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Steven Cohen’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,250
Closed -$445K – 1362
2021
Q3 		$445K Buy
+6,250
New +$711K ﹤0.01% 930

Other funds holding ASLN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Steven Cohen's ASLN Position: Q4 2021 in Review

Steven Cohen sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2021, closing a stake of 6,250 shares — an estimated $445K sold.

Steven Cohen first reported a position in ASLN in Q3 2021 and held it in 1 quarter. The position peaked at $445K in Q3 2021. 33 funds tracked by Wall St. Rank hold ASLN as of Q4 2021.

  • Steven Cohen reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Steven Cohen sold 6,250 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2021, an estimated $445K.
  • Steven Cohen first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • Steven Cohen's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $445K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2021.

Based on Point72 Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.